Q1 2026 ImmuCell Corp Earnings Call Transcript
Key Points
- ImmuCell Corp (ICCC) achieved its first-ever $10 million revenue quarter, marking a significant milestone for the company.
- The company reported a 34% increase in net income compared to the first quarter of 2025, demonstrating strong financial performance.
- Gross margins improved to 45% despite absorbing legacy costs, indicating effective cost management and operational efficiency.
- The company's flagship product, TriShield, saw a 38.5% sales growth in the first quarter of 2026 compared to the same period in 2025.
- ImmuCell Corp (ICCC) expanded its share of the U.S. scours prevention market, with its First Defense product accounting for nearly 80% of total category dollar expansion in the quarter.
- International sales declined by 30.2% in the first quarter, highlighting challenges in expanding beyond the domestic market.
- Operating expenses increased to $2.7 million from $2.2 million in the first quarter of 2025, driven by investments in leadership and sales expansion.
- The company faced a headwind of 2.4% in gross margin due to costs associated with former retain assets.
- Other income decreased significantly due to a non-recurring insurance payment received in the first quarter of 2025.
- ImmuCell Corp (ICCC) continues to face challenges in manufacturing capacity and product availability, which have historically impacted its ability to meet market demand.
Good morning and welcome to the ImmuCell Corporation conference call to discuss unaudited first quarter 2026 financial results.
Today, all participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note, this event today is being recorded. I would now like to turn the conference call over to Joe Diaz of Lytham Partners. Please proceed.
Thank you, Chris. Good morning and welcome. As the operator indicated, my name is Joe Diaz with Lytham Partners. We are the investor relations consulting firm for ImmuCell. I thank you for joining us today to discuss the unaudited earnings for the first quarter ended March 31. 2026.
Listeners are reminded and cautioned that statements made by management during the course of this call include forward-looking statements, which include any statement that refers to future events or expected future results or predictions about the steps the company plans to take in the future. These statements are not
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
